LOUMEAU ERIC J — SEC Form 4 filings
SEC reporting owner CIK 1239648. 12 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-09 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 10 filings — 85,518 shares, $3,651,171 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: sale of 10,000 shares @ $54.00 ($540,000) in ANAPTYSBIO, INC, filed 2026-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANAPTYSBIO, INC (ANAB) | CHIEF LEGAL OFFICER | 12 | — | 18 legs · 85,518 sh · $3,651,171 | 37 |
Form 4 filings — LOUMEAU ERIC J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-13 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,000 @ $29.70 · Sale (S): 10,000 @ $54 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,888 · Sale (S): 2,210 @ $44.71 · Option exercise (M): 5,888 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,545 · Sale (S): 2,017 @ $45.11 · Sale (S): 5,281 @ $45.38 · Sale (S): 1,841 @ $46.13 · Sale (S): 500 @ $47.23 · Option exercise (M): 5,545 (derivative) @ $0 · +2 more | EDGAR |
| 2026-01-06 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 7,287 · Sale (S): 2,983 @ $43.26 · Option exercise (M): 7,287 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,000 @ $14.02 · Sale (S): 10,000 @ $51 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,000 @ $14.02 · Option exercise (M): 7,500 @ $20.16 · Sale (S): 8,305 @ $44.68 · Sale (S): 4,195 @ $45.24 · Option exercise (M): 10,000 @ $14.02 · Sale (S): 10,000 @ $46 · +4 more | EDGAR |
| 2025-10-01 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,000 @ $14.02 · Sale (S): 8,240 @ $29 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 7,288 · Tax withholding (F): 2,994 @ $14.60 · Option exercise (M): 5,545 · Tax withholding (F): 2,217 @ $15.30 · Option exercise (M): 7,288 (derivative) @ $0 · Option exercise (M): 5,545 (derivative) @ $0 · +2 more | EDGAR |
| 2024-09-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,000 @ $0 · Sale (S): 2,220 @ $38.93 · Option exercise (M): 5,000 @ $14.02 · Sale (S): 6,500 @ $40.13 · Sale (S): 3,780 @ $38.41 · Option exercise (M): 6,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-24 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,000 @ $14.02 · Sale (S): 5,000 @ $25 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,545 @ $0 · Sale (S): 2,305 @ $21.81 · Option exercise (M): 5,545 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1239648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →